Inactivated vaccine · VDDBV0273
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT00561002 | Approved | Influenza |
| NCT00988143 | Phase 2 | Influenza |
| NCT02987374 | Approved | Influenza |
| NCT00959049 | Phase 3 | Influenza |
| NCT04077424 | Approved | Flu Vaccine |
| NCT03020537 | Approved | Influenza |
| NCT00231920 | Phase 1 | Influenza |
| NCT04101838 | Approved | Influenza |
| NCT02267733 | Phase 1 | Influenza |
| NCT03945825 | Phase 1 | Influenza |
| NCT02566265 | Phase 2 | Influenza |
| NCT03139565 | Phase 3 | Influenza |
| NCT02263040 | Phase 2 | Influenza |
| NCT00504231 | Phase 2 | Influenza |
| NCT03546192 | Approved | Influenza |
| NCT02563093 | Approved | Influenza |
| NCT02908269 | Approved | Influenza |
| NCT03617523 | Approved | Influenza |
| NCT02915302 | Approved | Influenza |
| NCT04551677 | Approved | Influenza |
| NCT05050318 | Approved | Influenza |
| NCT04109222 | Approved | Influenza |
| NCT03308825 | Approved | Influenza|Flu |
| NCT00662272 | Phase 1 | Influenza |
| NCT00623181 | Phase 2 | Influenza |
| NCT05291676 | Phase 2 | Influenza |
| NCT03020498 | Approved | Influenza |
| NCT00538512 | Approved | Influenza |
| NCT00170508 | — | Influenza |
| NCT01224262 | Phase 2 | Influenza |
| NCT00283283 | Phase 2 | Influenza |
| NCT00253734 | Phase 2 | Influenza |
| NCT02141581 | Approved | Influenza |
| NCT01987349 | Approved | Influenza |
| NCT02133781 | Approved | Influenza |
| NCT02134184 | Approved | Influenza |
| NCT02539108 | Approved | Influenza |
| NCT02222870 | Approved | Influenza |
| NCT01946425 | Approved | Influenza |
| NCT02258334 | Approved | Influenza |
| NCT01946438 | Approved | Influenza |
| NCT03312699 | Approved | Influenza |
| NCT03023176 | Approved | Influenza |
| NCT00936468 | Phase 2 | Influenza |
| NCT00258830 | Approved | Influenza |
| NCT00831987 | Approved | Influenza |
| NCT01691326 | Approved | Influenza |
| NCT00905125 | Phase 2 | Influenza |
| NCT03023553 | Approved | Influenza |
| NCT03023709 | Approved | Influenza |
| NCT03028987 | Approved | Influenza |
| NCT03028974 | Approved | Influenza |
| NCT03453801 | Phase 1 | Influenza |
| NCT00389532 | Approved | Influenza |
| NCT00258817 | Approved | Influenza |
| NCT00389857 | Approved | Influenza |
| NCT00390884 | Approved | Influenza |
| NCT01430819 | Approved | Influenza |
| NCT01691339 | Approved | Influenza |
| NCT00133510 | Approved | Influenza |
| NCT03022422 | Approved | Influenza |
| NCT03022435 | Approved | Influenza |
| NCT01232868 | — | Influenza |
| NCT03022396 | Approved | Influenza |
| NCT00743275 | Approved | Influenza |